Mater Oblia Hospital
Mater Oblia Hospital
Włochy, Rzym
Uterine cancer treatment cost in Italy typically includes a PET/CT scan ranging from $1,200 to $1,700 and surgical options like a hysterectomy (uterus removal) which runs from $12,000 to $22,000. Total expenses depend on the cancer stage, chosen surgical method, and facility tier. Patients often find 30-50% savings compared to the US. Leading treatment centers are located in Milan, Rome, and Bari.
Typical Uterine Cancer Treatment Costs in Italy
Bookimed Expert Insight: For early-stage uterine cancer, minimally invasive surgery is the gold standard. Mater Olbia Hospital in Rome offers excellence in laparoscopic approaches within a modern facility. Patients with advanced cases benefit from the expertise of Dr. Giorgia Mangili at San Raffaele. Her 20-year focus on gynecological oncology is ideal for complex cases requiring multidisciplinary care. Ospedale Santa Maria provides highly-ranked screening programs for diagnostic clarity.
| Włochy | Turcja | Austria | |
| Radioterapia przy raku macicy | od $14,500 | od $4,000 | od $6,921 |
| Laparoskopowa histerektomia | od $10,000 | od $7,000 | od $15,000 |
| Hormonterapia | od $2,500 | od $404 | od $7,000 |
| Histerektomia z użyciem robota Da Vinci | od $18,000 | od $11,000 | od $16,000 |
| Histerektomia (usunięcie macicy) | od $12,000 | od $4,760 | od $15,000 |
Państwo nie płacą za usługi Bookimed. Ceny leczenia raka macicy odpowiadają cennikowi kliniki. Płatność dokonywana jest bezpośrednio w klinice po przyjeździe. Dostępna jest płatność w ratach.
Bookimed dba o Państwa bezpieczeństwo. Współpracujemy tylko z klinikami spełniającymi wysokie międzynarodowe standardy w leczeniu raka macicy. Posiadają one wymagane licencje do obsługi pacjentów międzynarodowych na całym świecie.
Bookimed oferuje bezpłatną pomoc i wsparcie. Osobisty koordynator medyczny pozostaje w kontakcie przed, w trakcie i po podróży. Nie będą Państwo sami w innym kraju podczas leczenia raka macicy.
Prof. Deraco z powodzeniem wyleczył ponad 1200 pacjentów w szpitalu Maria Cecilia, stosując zaawansowane techniki leczenia otrzewnej, takie jak CRS, HIPEC i PIPAC.
Kierownik Oddziału Ginekologii Onkologicznej w Szpitalu San Raffaele, specjalizujący się w rzadkich nowotworach ginekologicznych oraz zachowaniu płodności w onkologii.
Italy offers advanced uterine cancer treatment through specialized Scientific Institutes for Research and Healthcare (IRCCS). Leading centers like Policlinico Universitario A. Gemelli and European Institute of Oncology utilize DaVinci robotic surgery and precision medicine. These facilities hold European Society of Gynaecologic Oncology (ESGO) accreditation for surgical excellence.
Bookimed Expert Insight: While public university hospitals offer high surgery volumes, private collaborations like Mater Olbia Hospital provide identical expertise from Fondazione Gemelli with shorter wait times. Choosing a facility with a dedicated Breast Unit often ensures better multidisciplinary support due to integrated women health protocols. San Raffaele stands out for its specific focus on fertility preservation during oncological treatment.
Patient Consensus: Patients emphasize that traveling to high-volume units is vital because surgical outcomes improve with a team specializing only in gynecologic oncology. They also highlight that expert pathology reviews at major centers frequently lead to more accurate treatment plans.
Patients with suspected or confirmed uterine cancer should see a gynecologic oncologist rather than a general gynecologist. These specialists possess advanced training in complex staging and surgical oncology procedures. In Italy, centers like San Raffaele specialize in oncologic gynecological care and fertility preservation.
Bookimed Expert Insight: Italian medical structures often house separate units for routine care and complex oncology. Ospedale Santa Maria serves as a premier destination for female screenings. For cancer, specialized units lead by professors like Dr. Marcello Deraco offer advanced Intraperitoneal Chemotherapy. These dedicated units provide significantly deeper expertise than general gynecology departments.
Patient Consensus: Patients note that general gynecologists are essential gateways for initial referrals and ultrasounds. However, they emphasize moving to a gynecologic oncology unit immediately for surgical planning and staging.
First-line treatment for uterine cancer in Italy is surgical resection. This typically involves a total hysterectomy and bilateral salpingo-oophorectomy. Italian protocols follow European Society of Gynaecological Oncology standards. Surgeons prioritize minimally invasive methods like laparoscopy or robotic-assisted surgery for early-stage cases.
Bookimed Expert Insight: Italian oncology relies on a collaborative model where surgeons and nuclear medicine physicians work together. For instance, Dr. Marcello Deraco emphasizes specialized procedures like PIPAC for advanced cases. While surgery is primary, clinics like Ospedale Santa Maria integrate multidisciplinary units for comprehensive care. Patients benefit from this team-based approach in established regional centers.
Patient Consensus: Patients note that postmenopausal bleeding is the most common sign leading to diagnosis. They emphasize the importance of confirming the specific cancer subtype before starting therapy.
Need for chemotherapy or radiation therapy in Italy depends on your pathology results. Doctors evaluate tumor stage, grade, and lymph node involvement after surgery. Italian oncology protocols use these adjuvant therapies as a safety net to destroy microscopic cells and prevent recurrence.
Bookimed Expert Insight: Italian oncology thrives on highly specialized niches. While many centers offer standard hysterectomies, surgeons like Dr. Marcello Deraco at Maria Cecilia Hospital focus specifically on advanced peritoneal spread. This level of specialization means your post-op therapy isn't just a standard protocol. It is often tailored by doctors who have managed over 1,200 complex cases.
Patient Consensus: Patients often notes that the final treatment plan can shift after the pathology report arrives. Many highlight that seeking a second opinion from a gynecologic oncologist is helpful when deciding on additional therapy.
Advanced therapies including immunotherapy are widely available in Italy. The Italian Medicines Agency (AIFA) approves and reimburses various monoclonal antibodies. Italian centers utilize treatments like Pembrolizumab for advanced cases. High standards of care include European Society for Medical Oncology (ESMO) certified experts.
Bookimed Expert Insight: Italian gynecological oncology is highly concentrated in large multidisciplinary units like Ospedale Santa Maria in Bari or Maria Cecilia Hospital. Dr. Marcello Deraco at Maria Cecilia Hospital has performed over 1,200 advanced procedures. Large centers with over 100 doctors on staff typically offer broader access to systemic therapies than smaller clinics. Patients should prioritize facilities that integrate diagnostic molecular imaging with surgical expertise for the best results.
Patient Consensus: Patients emphasize that immunotherapy eligibility depends strictly on tumor molecular markers like MSI or MMR status. It is important to ask for a pathology workup early to confirm if these advanced therapies are an option for your specific case.
Italian centers prefer laparoscopic surgery for routine cases due to cost-effectiveness and widespread availability. Robotic platforms like DaVinci are the priority for complex uterine cancer cases in major referral hubs. These high-volume centers value the 3D visualization and precision of robotic systems for delicate resections.
Bookimed Expert Insight: While Italy has established centers like Ospedale Santa Maria in Bari, surgical choice often shifts based on the specific specialist. Dr. Giorgia Mangili at San Raffaele in Milan focuses on rare gynecological tumors where specific surgical expertise takes precedence over the technology used. Patients should look for centers that offer both laparoscopic and robotic options. This availability suggests the facility can tailor the approach to the tumor stage rather than equipment limits.
Patient Consensus: Patients note that surgeons may steer them toward robotics if the equipment is available locally. Many emphasize that a surgeon's experience with a technique matters more than the specific machine used.
Hospital stays in Italy for uterine cancer surgery typically last 2 to 7 days. Recovery usually takes 3 to 6 weeks. Minimally invasive methods like robotic surgery allow discharge within 48 hours. Italian centers like Mater Olbia Hospital utilize these advanced protocols to shorten hospitalization.
Bookimed Expert Insight: While many focus on the stay, the choice of equipment is vital. Italian centers like Mater Olbia Hospital in Rome combine high bed capacity with DaVinci robotic technology. This setup supports the Enhanced Recovery After Surgery (ERAS) protocol. This approach can reduce some hospital stays to just 3 days without compromising safety.
Patient Consensus: Patients note that while physical pain and mobility improve quickly, energy levels often lag behind. Many suggest planning for home assistance for the first 2 weeks, as fatigue persists longer than incision healing.